• ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 LIVE!™
Insights
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Coverage
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

California bill proposes to open veterinary cannabis conversations

August 5, 2019
Gabrielle Roman, Content Marketing Manager
dvm360, dvm360 September 2019, Volume 50, Issue 9

SB 627 would allow veterinarians to discuss cannabis and related products with clients without fear of sanctions.

A bill introduced in the California legislature could make it easier for veterinarians to talk to clients about cannabis in practice. Introduced by Sen. Cathleen Galgiani, a Democrat from Stockton, SB 627 proposes to allow “a qualified veterinarian, as defined, to discuss the use of medicinal cannabis or medicinal cannabis products on an animal patient” without fear of reprisal.

The definition of a “qualified” veterinarian, according to the bill, is “one who has completed a medicinal CE program approved by the American Association of Veterinary State Boards' Registry of Approved Continuing Education.”

The California Veterinary Medical Association has voiced opposition to the “qualified” designation, stating, “The Veterinary Medicine Practice Act does not create a qualifying professional designation like this for any other drug that is prescribed by a licensed veterinarian. Consequently, we feel this designation for one product is inappropriate.”

In response, the Assembly Committee on Business and Professions proposed in its July 2 hearing to change all references to a “qualified” veterinarian to instead say a “California-licensed” veterinarian. “All veterinarians, by virtue of their license, have the education and skills needed to recommend drugs, including cannabis,” the committee asserted. “Whether a veterinarian chooses to recommend cannabis to their client would be subject to their own professional judgement.”

To allow veterinarians more freedom to discuss medical cannabis and related products with clients, the bill would DVMs “from being punished, or denied any right or privilege, for having recommended medicinal cannabis or medicinal cannabis products for an animal patient for medical purposes.”

However, veterinarians would potentially be subject to discipline if they did not follow the given restrictions:

  • There must be an established relationship between the veterinarian, client and patient for which medicinal cannabis is being recommended.
  • The veterinarian must specify the medical condition for which the product is being recommended and include the name of the patient and the patient's primary caregiver in the recommendation.
  • The veterinarian must perform an examination and identify a medical indication before recommending medicinal cannabis or related products.
  • A veterinarian cannot recommend medicinal cannabis if he or she has a financial relationship with a person or entity that dispenses medicinal cannabis.
  • Veterinarians cannot advertise that they offer recommendations for medical cannabis, and they cannot actually dispense or administer cannabis or cannabis products to patients.

San Francisco-based marijuana grower Lovingly and Legally is a sponsor of the bill, as are the American College of Veterinary Botanical Medicine and the American Holistic Veterinary Medical Association, which issued this statement: “Thousands of people are currently using cannabis for their pets with questionable advice from the internet or potentially unreliable advice from budtenders. Pet owners deserve the most reliable information possible regarding their pet's health and well-being. That information and advice is expected to come from trusted veterinarians.”

VetCBD, which sells veterinary-formulated CBD products, requested during the committee hearing that an amendment be added to the bill to clarify “that all adults age 21 and over would be able to purchase medicinal cannabis products for their animals, even if they had not received a veterinarian's recommendation.”

The Assembly Committee on Business and Professions listed a major concern being the lack of research regarding cannabis and animals. They noted that the Center of Medicinal Cannabis Research in California has done no studies on the efficacy of cannabis in animals. As a result, the committee suggested adding a research requirement-and providing funding for that research-in the bill itself.

The committee voted to pass the bill on July 9 and re-referred it to the Appropriations Committee.

download issueDownload Issue: dvm360 September 2019

Related Content:

Leadership & Personal GrowthRegulatoryLaw & EthicsBreaking NewsPoliticsClient Relations & Marketingdvm360 September 2019
How do you know who you want to become in your career?
How do you know who you want to become in your career?
Valuing core values at the veterinary clinic
Valuing core values at the veterinary clinic
This week on dvm360: Identifying malignant oral tumors, plus more veterinary news
This week on dvm360: Identifying malignant oral tumors, plus more veterinary news

Latest News

Banfield celebrates 150 million pet visits

Veterinary recruiting in the age of Zoom interviews

Maximizing adherence to minimize heartworm resistance

Whistle unveils Whistle Health

View More Latest News